Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 15 of 15 entries
View as:
Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer
Phase: N/A
Priority: Normal
Start: 02/29/00
End: 05/31/01
Due: 05/31/02
Phase: N/A
Priority: Normal
Start: 05/31/94
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/93
End: 05/31/94
Due: 05/31/95
Phase: N/A
Priority: Normal
Start: 07/31/00
End: 11/30/01
Due: 11/30/02
Phase: N/A
Priority: Normal
Start: 08/31/00
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: 08/31/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/99
End: 02/28/02
Due: 02/28/03
Phase: N/A
Priority: Normal
Start: 04/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/14/00
End: 09/19/02
Due: 09/19/03
Phase: N/A
Priority: Normal
Start: 04/30/00
End: 02/28/01
Due: 02/28/02
Phase: N/A
Priority: Normal
Start: 02/28/01
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 09/30/98
End: 01/31/01
Due: 01/31/02
Phase: N/A
Priority: Normal
Start: 08/31/99
End: 05/31/02
Due: 05/31/03
Phase: N/A
Priority: Normal
Start: 02/28/01
End: 12/31/02
Due: 12/31/03